If you work in pharmacovigilance or drug safety, you know how much structure goes into post-market monitoring and adverse event reporting. Clinical trials, non-interventional studies, and patient surveys are all essential, but even with these systems in place, critical signals can be missed. Even when spontaneous reports are in place, most adverse drug reactions never […]
